These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8759618)

  • 1. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
    Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
    Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment.
    Wikström P; Bergh A; Damber JE
    Urol Res; 1997; 25(2):103-11. PubMed ID: 9144876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
    Lindström P; Bergh A; Holm I; Damber JE
    Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
    Wong YC; Xie W; Tsao SW
    Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in rat prostatic adenocarcinoma is associated with rapid infiltration of cytotoxic T-cells and activated macrophages.
    Landström M; Funa K
    Int J Cancer; 1997 May; 71(3):451-5. PubMed ID: 9139883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A
    Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients.
    Wikström P; Westin P; Stattin P; Damber JE; Bergh A
    Prostate; 1999 Mar; 38(4):268-77. PubMed ID: 10075006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration.
    Brodin G; ten Dijke P; Funa K; Heldin CH; Landström M
    Cancer Res; 1999 Jun; 59(11):2731-8. PubMed ID: 10363999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta1) type I and type II receptors in human prostate cancer.
    Guo Y; Jacobs SC; Kyprianou N
    Int J Cancer; 1997 May; 71(4):573-9. PubMed ID: 9178810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.
    Gold LI; Sung JJ; Siebert JW; Longaker MT
    Am J Pathol; 1997 Jan; 150(1):209-22. PubMed ID: 9006337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression.
    Tu H; Jacobs SC; Borkowski A; Kyprianou N
    Int J Cancer; 1996 Oct; 69(5):357-63. PubMed ID: 8900367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.